Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 838 (LINC00838) is a member of the long intergenic non-coding RNA (lincRNA) family, characterized as a non-protein coding RNA longer than 200 nucleotides that does not overlap any coding genes. LINC00838, like other lincRNAs, is transcribed but not translated into protein, and may function in chromatin remodeling, modulating genome architecture, transcriptional regulation, and RNA stabilization. Its biological roles are largely uncharacterized, and as of now, there are no well-documented disease associations, drug interactions, or known therapeutic targeting for LINC00838. The broader class of lincRNAs can play roles in gene regulation and disease, but specific data concerning LINC00838 are currently limited[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 838 (LINC00838).